Implementation of an Evidence Based Parentally Administered Intervention for Preterm Infants
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Premature Infants
- Sponsor
- Medical College of Wisconsin
- Enrollment
- 1882
- Locations
- 4
- Primary Endpoint
- Aim 1 Outcome Measure: Implementation Success (Percent Change in Sustainability throughout implementation)
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
Early developmentally-based behavioral intervention has well-established positive effects and is recommended as the standard of care to support early brain maturation, health, and development. However, few neonatal intensive care units (NICUs) provide this early intervention. H-HOPE (Hospital to Home: Optimizing the Preterm Infant's Environment) has established efficacy, and has a standardized protocol, making it ready for widespread implementation. The infant-directed component of H-HOPE provides Auditory (voice), Tactile (moderate touch massage), Visual (eye to eye), and Vestibular (rocking) stimulation starting when infants are ready for social interaction. The parent-directed component of H-HOPE includes participatory guidance and support to help parents engage with infants in the NICU and the transition to home. In this NIH-funded research, H-HOPE improved growth, developmental maturity and mother-infant interaction, and reduced initial hospitalization costs and acute care visits through 6-weeks corrected age. This research tests whether H-HOPE can be implemented and sustained in five diverse NICUs, using a Type 3 Hybrid design to evaluate both implementation processes and effectiveness. The specific aims are to: 1) Identify the degree of implementation success; 2) Evaluate the effectiveness of H-HOPE for infants, hospital costs from H-HOPE enrollment until discharge, and parents, compared to a pre-implementation comparison cohort; and 3) Determine influences (facilitators and barriers) associated with implementation success and H-HOPE effectiveness, guided by the Consolidated Framework for Implementation Research (CFIR). An incomplete stepped-wedge design guides staggered roll-out for five clinical sites. Each NICU completes the CFIR implementation steps (Planning and Engaging, Executing, and Reflecting and Evaluating), followed by 6 months of Sustaining. For Aim 1, degree of implementation success is determined every two months as Sustainability (still offering H-HOPE), Reach (% of eligible parent/infant dyads receiving H-HOPE) and Degree of Implementation (mean H-HOPE services received per parent-infant unit) (primary implementation outcomes). For Aim 2, effectiveness is analyzed using generalized linear mixed models for infant, cost, and parent outcomes (primary outcomes: infant growth at discharge and acute care visits from discharge to 6-weeks corrected age). Propensity score analysis is used to make the pre- and post-implementation comparable. For Aim 3, a mixed methods analyses is used to identify influences from H-HOPE records and interviews that are associated with implementation success and effectiveness at each site and across sites. This is the first time implementation in a NICU is guided by the evidence-based CFIR framework, and results will make a major contribution to implementation science. This study will produce an evidence-based implementation strategy and Toolkit to disseminate nationwide. Widespread H-HOPE implementation will make a significant change in clinical practice and improve preterm infant health and health care costs.
Investigators
Rosemary White-Traut
Director of Nursing Research and Evidence Based Practice
Medical College of Wisconsin
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Aim 1 Outcome Measure: Implementation Success (Percent Change in Sustainability throughout implementation)
Time Frame: Every 2 months from Executing through 6 months after supported implementation ends
Change in % of instances of H-HOPE being offered
Aim 1 Outcome Measure: Implementation Success (Change in Reach throughout implementation)
Time Frame: Every 2 months from Executing through 6 months after supported implementation ends
% of eligible parent-infant units receiving H-HOPE
Aim 1 Outcome Measure: Implementation Success (Degree of Implementation)
Time Frame: Every 2 months from Executing through 6 months after supported implementation ends
In-Hospital: Infant: Mean number of ATVV interventions received per eligible day (Range 0-2) Transition to home: Parents: # received participatory guidance sessions (2 pre-discharge and 2 screen time visits at 2-3 days and 7-15 days post-discharge; Range: 0-3) Infant: Mean number of ATVV interventions received by per eligible day since discharge (Range 0-2; provided and reported by parent)
Aim 2 Outcome Measure: Effectiveness-(Change in Infant Head Circumference)
Time Frame: From birth to discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Infant Primary: Infant Head Circumference, measured in centimeters.
Aim 2 Outcome Measure: Effectiveness (Change in Infant Weight)
Time Frame: From birth to discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Infant Primary: Weight, measured in kilograms
Aim 2 Outcome Measure: Effectiveness (Change in Infant Length)
Time Frame: From birth to discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant)
Infant Primary: Length, measured in centimeters
Aim 2 Outcome Measure: Effectiveness (Change in number of Acute Care Visits)
Time Frame: At 6 weeks post discharge
Number of acute care visits (clinic or emergency department visit or re-hospitalization)
Secondary Outcomes
- Aim 2 Outcome Measure: Cost(From infant enrollment through infant discharge (an average of 31- 48 weeks PMA (Post Menstrual Age) of infant))
- Aim 3 Outcome Measure: CFIR influences (Number of facilitators and barriers to implementation)(From the completion of the first site's Sustaining Phase through Final Analysis of all site data, estimated to be 39 months.)